Supernus Pharmaceuticals | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
Abbott USD 5.5B 184M 2024-03
ANI Pharmaceuticals USD 88.27M 10.04M 2024-03
Aurora Cannabis CAD -2939000 2.94M 2023-12
Bristol-Myers Squibb USD 8.93B 163M 2024-03
Canopy Growth CAD 15.47M 12.76M 2024-03
Corcept Therapeutics USD 144.27M 22.32M 2024-03
Eisai JPY 138.82B 1.37B 2023-12
Eli Lilly USD 7.09B 470.9M 2024-03
Pacira USD 119.7M 13.85M 2024-03
Perrigo USD 357.7M 69.6M 2024-03
Pfizer USD 11.5B 3.92B 2024-03
Supernus Pharmaceuticals USD 127.34M 17.35M 2024-03
United Therapeutics USD 604.8M 61.1M 2024-03
Xeris Pharmaceuticals USD 34.67M 2.15M 2024-03



Supernus Pharmaceuticals Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.